FDA Launches Major Review of CGMPs

October 2, 2002
Jill Wechsler
Pharmaceutical Technology

Volume 26, Issue 10

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.